STOCK OPTION PLANS AND WARRANTS (Details - Warrants outstanding) - USD ($) |
9 Months Ended | 12 Months Ended | |
|---|---|---|---|
Aug. 12, 2026 |
Sep. 30, 2026 |
Dec. 31, 2025 |
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Weighted average exercise price - ending | $ 0.50 | ||
| Warrant [Member] | |||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | |||
| Warrants outstanding, beginning balance | 846,668 | ||
| Weighted average exercise price - beginning | $ 45.61 | ||
| Weighted average contractual term | 2 years 5 months 23 days | 2 years 6 months 7 days | |
| Aggregate intrinsic value, beginning balance | $ 142,600 | ||
| Warrants granted | 1,620,000 | ||
| Weighted average exercise price, granted | $ 0.50 | ||
| Weighted average contractual term, granted | 2 years 10 months 6 days | ||
| Aggregate intrinsic value, granted | $ 0 | ||
| Cancelled or expired | (3,750) | ||
| Warrants outstanding, ending balance | 2,462,918 | 846,668 | |
| Weighted average exercise price - ending | $ 15.78 | $ 45.61 | |
| Aggregate intrinsic value, ending balance | $ 0 | $ 142,600 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for outstanding stock option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|